Patent assignee · COMPANY

AstraZeneca

22Patents
12Active
22Granted
55Portfolio score

Filing activity: Sep 18, 2000 → Jun 12, 2023 · 7 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US6710052B2 Pyrimidine compounds Chemistry; Metallurgy 74 Expired
US8012964B2 9-substituted 8-oxoadenine compound Human Necessities 33 Active
US9376398B2 Carboxylic acid compounds Emerging Cross-Sectional Technologies 32 Active
US6875872B1 Compounds Chemistry; Metallurgy 23 Expired
US7067532B2 Substituted quinolines as antitumor agents Chemistry; Metallurgy 21 Expired
US6784171B2 Process for the production of tert-butyl (E)-(6-[2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl](4R,6S)-2, 2-dimethyl[1, 3]dioxan-4-yl)acetate Emerging Cross-Sectional Technologies 19 Expired
US8575180B2 9-substituted 8-oxoadenine compound Human Necessities 19 Active
US7709479B1 Quinazoline derivatives and their use as pharmaceuticals Emerging Cross-Sectional Technologies 13 Expired
US8371449B2 Package Performing Operations; Transporting 9 Active
US6911458B2 Compounds Human Necessities 4 Expired
US8148540B2 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents Emerging Cross-Sectional Technologies 4 Active
US7115615B2 Quinazoline derivatives Chemistry; Metallurgy 3 Expired
US8044056B2 Adenine compound Chemistry; Metallurgy 2 Active
US8038006B2 Blister-type packaging for inhalers Human Necessities 1 Active
US7645751B2 Mandelic acid derivatives and their use as thrombin inhibitors Chemistry; Metallurgy 1 Active
US7622482B2 Chemical compounds Chemistry; Metallurgy 0 Expired
US11858924B2 N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides Chemistry; Metallurgy 0 Active
US6723723B1 Heterocyclic derivatives as inhibitors of factor Xa Human Necessities 0 Expired
US7897778B2 Benzamide compounds Chemistry; Metallurgy 0 Active
US8969362B2 9-substituted 8-oxoadenine compound Human Necessities 0 Active
US8865896B2 Method for preparing adenine compound Human Necessities 0 Active
US7579342B2 Pteridine compounds for the treatment of psoriasis Chemistry; Metallurgy 0 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.